Voorbeelden van het gebruik van Have not been evaluated in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Testimonial on this website have not been evaluated by the EU or other bodies.
Developmental safety data in this population have not been evaluated.
Instanyl in doses above 400 micrograms have not been evaluated in clinical trials.
enforcement of this law have not been evaluated.
serious infections have not been evaluated.
Pharmacokinetics and pharmacodynamics of prasugrel have not been evaluated in a paediatric population see section 4.2.
efficacy of Orkambi in patients aged 65 years or older have not been evaluated.
Safety and efficacy have not been evaluated in older people and the use of dexrazoxane in such patients is not recommended.
efficacy of Lonquex have not been evaluated in patients receiving chemotherapy associated with delayed myelosuppression, e.g. nitrosoureas.
Doses greater than 650 mg/ m2/ day have not been evaluated in patients with CTCL.
efficacy of the combination of Cotellic and vemurafenib have not been evaluated in patients with a BRAF V600 mutation-positive melanoma which has metastasised to the brain.
efficacy of the combination of trametinib and dabrafenib have not been evaluated in patients with a BRAF V600 mutation-positive melanoma which has metastasised to the brain.
efficacy of Oxyglobin have not been evaluated in dogs with thrombocytopenia with active bleeding,
This product is a dietary supplement and statements have not been evaluated by the food and.
Safety and efficacy of lasofoxifene have not been evaluated in patients with severe renal insufficiency;
Safety and efficacy of FABLYN have not been evaluated in patients with liver function test>
forms of interferon(i.e. not alfa-2b) in these patients have not been evaluated.
chronic infections have not been evaluated.
The pharmacokinetics of CE/bazedoxifene have not been evaluated in patients with renal impairment.
Viramune prolonged-release tablets have not been evaluated in patients with hepatic impairment